Sales growth drives Cochlear recovery
Hearing implant technology company Cochlear has emerged from a Covid-19 slowdown stronger than before, today reporting sales revenue up 10 per cent in FY21 compared to last year and six per cent above pre-Covid levels. Market growth, market share gains and the re-scheduling of surgeries postponed at the height of the pandemic saw implant sales…
Details










